nifedipine has been researched along with Hypertension, Pregnancy-Induced in 54 studies
Nifedipine: A potent vasodilator agent with calcium antagonistic action. It is a useful anti-anginal agent that also lowers blood pressure.
Hypertension, Pregnancy-Induced: A condition in pregnant women with elevated systolic (
| Excerpt | Relevance | Reference |
|---|---|---|
| "We evaluated whether combined oral hydrochlorothiazide and lisinopril therapy produced superior short-term blood pressure control when compared with nifedipine among postpartum individuals with hypertension requiring pharmacologic treatment." | 9.69 | Oral combined hydrochlorothiazide and lisinopril vs nifedipine for postpartum hypertension: a comparative-effectiveness pilot randomized controlled trial. ( Amro, F; Blackwell, SC; Chauhan, SP; Fishel Bartal, M; Lawal, D; Pedroza, C; Samuel, J; Sibai, BM, 2023) |
| "The purpose is to investigate the influence of nifedipine, labetalol, and magnesium sulfate on blood pressure control, blood coagulation, and maternal and infant outcome in those suffering from pregnancy-induced hypertension (PIH)." | 9.51 | Effects of Nifedipine and Labetalol Combined with Magnesium Sulfate on Blood Pressure Control, Blood Coagulation Function, and Maternal and Infant Outcome in Patients with Pregnancy-Induced Hypertension. ( Gu, S; Shao, Y; Zhang, X, 2022) |
| "To compare oral nifedipine and intravenous labetalol in the treatment of acute severe hypertension in pregnancy (SHP)." | 9.41 | Oral nifedipine may be a preferential option for treating acute severe hypertension during pregnancy: a meta-analysis. ( Cui, S; Ou, M; Yu, Y; Zhang, F; Zhao, S, 2023) |
| "To compare the change in cerebral perfusion pressure before and after intravenous labetalol vs oral nifedipine in the setting of acute severe hypertension in pregnancy." | 9.34 | Intravenous labetalol versus oral nifedipine for acute hypertension in pregnancy: effects on cerebral perfusion pressure. ( Belfort, MA; Clark, SL; Fox, KA; Sangi-Haghpeykar, H; Tolcher, MC, 2020) |
| "To compare the efficacy of intravenous labetalol with oral nifedipine in the treatment of severe hypertension in pregnancy with blood pressure ≥160/110 mm Hg." | 9.30 | IV labetalol and oral nifedipine in acute control of severe hypertension in pregnancy-A randomized controlled trial. ( Sowjanya, R; Tatapudi, R; Zulfeen, M, 2019) |
| "490 pregnant women with mild to moderate chronic hypertension were randomized into three groups; methyldopa group (n = 166), nifedipine group (n = 160) and control or no medication group (n = 164) who were followed from the beginning of pregnancy till the end of puerperium to record maternal and fetal outcome." | 9.30 | Methyldopa versus nifedipine or no medication for treatment of chronic hypertension during pregnancy: A multicenter randomized clinical trial. ( Abdallah, S; Gaber, W; Gamal, A; Hamza, H; Marawan, H; Rezk, M; Salama, M, 2019) |
| "Both intravenous hydralazine and oral nifedipine are equally effective in lowering of blood pressure in acute hypertensive emergency of pregnancy." | 9.24 | Hydralazine vs nifedipine for acute hypertensive emergency in pregnancy: a randomized controlled trial. ( Gupta, A; Sharma, C; Soni, A; Verma, A; Verma, S, 2017) |
| "These findings demonstrated the superiority of oral nifedipine 50,60,90 mg, especially oral nifedipine 50 mg tablets, in the treatment of severe hypertension during pregnancy than IV labetalol 300 mg, while oral nifedipine 60,90 mg also showed superiority in the successful treatment rate of severe hypertension during pregnancy than IV hydralazine 15,25 mg." | 9.22 | Different dosage regimens of nifedipine, labetalol, and hydralazine for the treatment of severe hypertension during pregnancy: a network meta-analysis of randomized controlled trials. ( Cheng, Y; Jiang, YF; Li, JB; Wu, HZ; Yu, D; Zhu, ZN, 2022) |
| " Methyldopa, labetalol, and nifedipine have been perceived safe to use during pregnancy and are therefore recommended in international guidelines for treatment of hypertension." | 9.22 | Pharmacokinetics of the most commonly used antihypertensive drugs throughout pregnancy methyldopa, labetalol, and nifedipine: a systematic review. ( Allegaert, K; Flint, RB; Mian, P; Schoenmakers, S; van de Vusse, D; Versmissen, J; Visser, W, 2022) |
| "As administered in this trial, oral nifedipine lowered blood pressure more quickly than did intravenous labetalol during hypertensive emergency in pregnancy." | 9.17 | Oral nifedipine or intravenous labetalol for hypertensive emergency in pregnancy: a randomized controlled trial. ( Sharma, C; Shekhar, S; Thakur, S; Verma, S, 2013) |
| "Oral nifedipine and intravenous labetalol regimens are similarly effective in the acute control of severe hypertension in pregnancy." | 9.16 | Oral nifedipine versus intravenous labetalol for acute blood pressure control in hypertensive emergencies of pregnancy: a randomised trial. ( Omar, SZ; Raheem, IA; Saaid, R; Tan, PC, 2012) |
| "We included all RCTs that compared intravenous labetalol with oral nifedipine for treatment of severe hypertension during pregnancy, addressing relevant efficacy and safety outcomes." | 8.93 | Oral nifedipine versus intravenous labetalol for severe hypertension during pregnancy: a systematic review and meta-analysis. ( Gupta, N; Kirubakaran, R; Pareek, P; Shekhar, S, 2016) |
| "To assess whether readmission for hypertension by 6 weeks postpartum differed between patients discharged on nifedipine or labetalol." | 8.12 | Postpartum Readmission for Hypertension After Discharge on Labetalol or Nifedipine. ( Do, SC; Druzin, ML; El-Sayed, YY; Girsen, AI; Herrero, T; Kan, P; Leonard, SA; Lyell, DJ; Panelli, DM, 2022) |
| "A retrospective study in hypertensive patients treated during pregnancy with nifedipine or labetalol was conducted." | 7.78 | Nifedipine versus labetalol in the treatment of hypertensive disorders of pregnancy. ( Battistoni, GI; Bezzeccheri, V; Cecchi, L; Cecchi, S; Giannubilo, SR; Landi, B; Tranquilli, AL; Vitali, P, 2012) |
| "Investigation of methyldopa and nifedipine effects on maternal and fetal hemodynamics in women with mild gestational hypertension during the third pregnancy trimester." | 7.78 | Effects of methyldopa and nifedipine on uteroplacental and fetal hemodynamics in gestational hypertension. ( Folic, MD; Folic, MM; Jankovic, SM; Varjacic, MR, 2012) |
| "Alpha-methyldopa is a regularly used antihypertensive drug during pregnancy." | 7.76 | [Methyldopa-induced acute reactive hepatitis in pregnancy, drug-metabolizing capacity of the liver]. ( Monostory, K; Ozsvár, Z; Solymossi, Z, 2010) |
| "A meta-analysis of randomized controlled trials suggests that nifedipine appears to be a reasonable agent for treatment of acute severe hypertension in pregnancy." | 7.73 | Nifedipine for severe hypertension in pregnancy: emotion or evidence? ( Côté, AM; Magee, LA; von Dadelszen, P, 2005) |
| "Nifedipine was found to be more effective than other antihypertensive medications to reduce blood pressure, particularly in patients with severe hypertension." | 6.82 | Comparative efficacy and safety of oral nifedipine with other antihypertensive medications in the management of hypertensive disorders of pregnancy: a systematic review and meta-analysis of randomized controlled trials. ( Adela, R; George, R; Joy, CA; Thomas, C; Undela, K; Varghese, B, 2022) |
| "We evaluated whether combined oral hydrochlorothiazide and lisinopril therapy produced superior short-term blood pressure control when compared with nifedipine among postpartum individuals with hypertension requiring pharmacologic treatment." | 5.69 | Oral combined hydrochlorothiazide and lisinopril vs nifedipine for postpartum hypertension: a comparative-effectiveness pilot randomized controlled trial. ( Amro, F; Blackwell, SC; Chauhan, SP; Fishel Bartal, M; Lawal, D; Pedroza, C; Samuel, J; Sibai, BM, 2023) |
| "The purpose is to investigate the influence of nifedipine, labetalol, and magnesium sulfate on blood pressure control, blood coagulation, and maternal and infant outcome in those suffering from pregnancy-induced hypertension (PIH)." | 5.51 | Effects of Nifedipine and Labetalol Combined with Magnesium Sulfate on Blood Pressure Control, Blood Coagulation Function, and Maternal and Infant Outcome in Patients with Pregnancy-Induced Hypertension. ( Gu, S; Shao, Y; Zhang, X, 2022) |
| "To compare oral nifedipine and intravenous labetalol in the treatment of acute severe hypertension in pregnancy (SHP)." | 5.41 | Oral nifedipine may be a preferential option for treating acute severe hypertension during pregnancy: a meta-analysis. ( Cui, S; Ou, M; Yu, Y; Zhang, F; Zhao, S, 2023) |
| "To compare the change in cerebral perfusion pressure before and after intravenous labetalol vs oral nifedipine in the setting of acute severe hypertension in pregnancy." | 5.34 | Intravenous labetalol versus oral nifedipine for acute hypertension in pregnancy: effects on cerebral perfusion pressure. ( Belfort, MA; Clark, SL; Fox, KA; Sangi-Haghpeykar, H; Tolcher, MC, 2020) |
| "The use of labetalol and nifedipine were not related to any significant changes in maternal Doppler, which is reassuring about the safety of these drugs when treating acute severe hypertension in pregnancy." | 5.34 | To study the changes in maternal hemodynamics with intravenous labetalol or nifedipine in acute severe hypertension. ( Gainder, S; Prakash, M; Saha, SC; Thakur, M, 2020) |
| "490 pregnant women with mild to moderate chronic hypertension were randomized into three groups; methyldopa group (n = 166), nifedipine group (n = 160) and control or no medication group (n = 164) who were followed from the beginning of pregnancy till the end of puerperium to record maternal and fetal outcome." | 5.30 | Methyldopa versus nifedipine or no medication for treatment of chronic hypertension during pregnancy: A multicenter randomized clinical trial. ( Abdallah, S; Gaber, W; Gamal, A; Hamza, H; Marawan, H; Rezk, M; Salama, M, 2019) |
| "To compare the efficacy of intravenous labetalol with oral nifedipine in the treatment of severe hypertension in pregnancy with blood pressure ≥160/110 mm Hg." | 5.30 | IV labetalol and oral nifedipine in acute control of severe hypertension in pregnancy-A randomized controlled trial. ( Sowjanya, R; Tatapudi, R; Zulfeen, M, 2019) |
| "Both intravenous hydralazine and oral nifedipine are equally effective in lowering of blood pressure in acute hypertensive emergency of pregnancy." | 5.24 | Hydralazine vs nifedipine for acute hypertensive emergency in pregnancy: a randomized controlled trial. ( Gupta, A; Sharma, C; Soni, A; Verma, A; Verma, S, 2017) |
| " Methyldopa, labetalol, and nifedipine have been perceived safe to use during pregnancy and are therefore recommended in international guidelines for treatment of hypertension." | 5.22 | Pharmacokinetics of the most commonly used antihypertensive drugs throughout pregnancy methyldopa, labetalol, and nifedipine: a systematic review. ( Allegaert, K; Flint, RB; Mian, P; Schoenmakers, S; van de Vusse, D; Versmissen, J; Visser, W, 2022) |
| "These findings demonstrated the superiority of oral nifedipine 50,60,90 mg, especially oral nifedipine 50 mg tablets, in the treatment of severe hypertension during pregnancy than IV labetalol 300 mg, while oral nifedipine 60,90 mg also showed superiority in the successful treatment rate of severe hypertension during pregnancy than IV hydralazine 15,25 mg." | 5.22 | Different dosage regimens of nifedipine, labetalol, and hydralazine for the treatment of severe hypertension during pregnancy: a network meta-analysis of randomized controlled trials. ( Cheng, Y; Jiang, YF; Li, JB; Wu, HZ; Yu, D; Zhu, ZN, 2022) |
| "As administered in this trial, oral nifedipine lowered blood pressure more quickly than did intravenous labetalol during hypertensive emergency in pregnancy." | 5.17 | Oral nifedipine or intravenous labetalol for hypertensive emergency in pregnancy: a randomized controlled trial. ( Sharma, C; Shekhar, S; Thakur, S; Verma, S, 2013) |
| "Oral nifedipine and intravenous labetalol regimens are similarly effective in the acute control of severe hypertension in pregnancy." | 5.16 | Oral nifedipine versus intravenous labetalol for acute blood pressure control in hypertensive emergencies of pregnancy: a randomised trial. ( Omar, SZ; Raheem, IA; Saaid, R; Tan, PC, 2012) |
| "A series of small pharmacokinetic studies illustrate higher oral clearance of labetalol and nifedipine during pregnancy." | 5.12 | The Impact of Pregnancy on Antihypertensive Drug Metabolism and Pharmacokinetics: Current Status and Future Directions. ( Daubert, MA; Fashe, MM; Garcia, JE; Lee, CR; Loop, MS; Mulrenin, IR; Urrutia, RP, 2021) |
| "The aim of the present study was to determine whether the beneficial effect of oral supplementation with calcium and conjugated linoleic acid (CLA) in the reduction of the incidence of pregnancy-induced hypertension (PIH) is related with changes in plasma levels of prostanoids, renin, angiotensin II, calciotropic hormones, and plasma and intracellular ionized free calcium." | 5.12 | Calcium and conjugated linoleic acid reduces pregnancy-induced hypertension and decreases intracellular calcium in lymphocytes. ( Arévalo-Herrera, M; Ersheng, G; Garcia, RG; Herrera, JA; Herrera, S; López-Jaramillo, P; Shahabuddin, AK, 2006) |
| "Hydralazine, labetalol, and nifedipine are the recommended first-line treatments for severe hypertension in pregnancy." | 5.01 | First-line antihypertensive treatment for severe hypertension in pregnancy: A systematic review and network meta-analysis. ( Alavifard, S; Chase, R; Chaumont, A; Gaudet, L; Janoudi, G; Lanes, A; Walker, M, 2019) |
| "We included all RCTs that compared intravenous labetalol with oral nifedipine for treatment of severe hypertension during pregnancy, addressing relevant efficacy and safety outcomes." | 4.93 | Oral nifedipine versus intravenous labetalol for severe hypertension during pregnancy: a systematic review and meta-analysis. ( Gupta, N; Kirubakaran, R; Pareek, P; Shekhar, S, 2016) |
| "Oral nifedipine, and possibly labetalol and methyldopa, are suitable options for treatment of severe hypertension in pregnancy/postpartum." | 4.90 | Oral antihypertensive therapy for severe hypertension in pregnancy and postpartum: a systematic review. ( Firoz, T; Gordon, R; MacDonell, K; Magee, LA; Payne, BA; Vidler, M; von Dadelszen, P, 2014) |
| "To assess whether readmission for hypertension by 6 weeks postpartum differed between patients discharged on nifedipine or labetalol." | 4.12 | Postpartum Readmission for Hypertension After Discharge on Labetalol or Nifedipine. ( Do, SC; Druzin, ML; El-Sayed, YY; Girsen, AI; Herrero, T; Kan, P; Leonard, SA; Lyell, DJ; Panelli, DM, 2022) |
| " The American College of Obstetricians and Gynecologists recommends that acute-onset, severe hypertension be treated with first line-therapy (intravenous labetalol, intravenous hydralazine or oral nifedipine) within 60 minutes to reduce risk of maternal morbidity and death." | 3.96 | Identification of factors associated with delayed treatment of obstetric hypertensive emergencies. ( Akerman, MB; Elsayad, A; Halpern, TA; Heiselman, CJ; Heo, HJ; Kantorowska, A; Muscat, JC; Sicuranza, GB; Vintzileos, AM, 2020) |
| "Nine mothers were treated with labetalol and/or MgSO4 during pregnancy, three mothers with labetalol, MgSO4 and nifedipine, and 19 mothers with nifedipine only." | 3.79 | Maternal antihypertensive drugs may influence cerebral oxygen extraction in preterm infants during the first days after birth. ( Bos, AF; Kooi, EM; van den Berg, PP; Verhagen, EA, 2013) |
| "Investigation of methyldopa and nifedipine effects on maternal and fetal hemodynamics in women with mild gestational hypertension during the third pregnancy trimester." | 3.78 | Effects of methyldopa and nifedipine on uteroplacental and fetal hemodynamics in gestational hypertension. ( Folic, MD; Folic, MM; Jankovic, SM; Varjacic, MR, 2012) |
| "A retrospective study in hypertensive patients treated during pregnancy with nifedipine or labetalol was conducted." | 3.78 | Nifedipine versus labetalol in the treatment of hypertensive disorders of pregnancy. ( Battistoni, GI; Bezzeccheri, V; Cecchi, L; Cecchi, S; Giannubilo, SR; Landi, B; Tranquilli, AL; Vitali, P, 2012) |
| "Labetalol is commonly used for control of hypertension in pregnancy." | 3.77 | False-positive amphetamine toxicology screen results in three pregnant women using labetalol. ( Wu, D; Yee, LM, 2011) |
| "Alpha-methyldopa is a regularly used antihypertensive drug during pregnancy." | 3.76 | [Methyldopa-induced acute reactive hepatitis in pregnancy, drug-metabolizing capacity of the liver]. ( Monostory, K; Ozsvár, Z; Solymossi, Z, 2010) |
| "A meta-analysis of randomized controlled trials suggests that nifedipine appears to be a reasonable agent for treatment of acute severe hypertension in pregnancy." | 3.73 | Nifedipine for severe hypertension in pregnancy: emotion or evidence? ( Côté, AM; Magee, LA; von Dadelszen, P, 2005) |
| "Hypertension during pregnancy is associated with a higher risk of cardiovascular disease and kidney failure." | 3.01 | Evaluation and Management of Hypertensive Disorders of Pregnancy. ( Bajpai, D; Dumanski, S; Popa, C; Shah, S; Verma, P, 2023) |
| "Nifedipine was found to be more effective than other antihypertensive medications to reduce blood pressure, particularly in patients with severe hypertension." | 2.82 | Comparative efficacy and safety of oral nifedipine with other antihypertensive medications in the management of hypertensive disorders of pregnancy: a systematic review and meta-analysis of randomized controlled trials. ( Adela, R; George, R; Joy, CA; Thomas, C; Undela, K; Varghese, B, 2022) |
| "Complications in early-onset mild gestational hypertension (GH) are better predicted by total peripheral vascular resistance (TPVR) > 1350 dyne than by blood pressure." | 2.77 | Medical treatment of early-onset mild gestational hypertension reduces total peripheral vascular resistance and influences maternal and fetal complications. ( Gagliardi, G; Giannini, L; Manfellotto, D; Novelli, GP; Pisani, I; Tiralongo, GM; Valensise, H; Vasapollo, B, 2012) |
| "Pregnancy-induced hypertension is a major cause of maternal and fetal morbidity and mortality." | 2.61 | Hypertension and Pregnancy: Management and Future Risks. ( Jim, B; Reddy, S, 2019) |
| "The HDP spectrum includes gestational hypertension (HTN), preeclampsia, eclampsia, HELLP (hemolysis, elevated liver enzymes, and low platelet count) syndrome, chronic HTN, and chronic HTN with superimposed preeclampsia." | 1.72 | Hypertensive Conditions: Hypertensive Disorders in Pregnancy. ( Daly, PL; Goodwin, ET; Kipnis, CM; Smith, DK, 2022) |
| "IgA nephropathy is one of the most common causes of renal hypertension." | 1.48 | Pregnancy-induced complications in IgA nephropathy: A case report. ( Chen, H; Fan, L; Li, X; Tian, G; Wu, Y, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (9.26) | 29.6817 |
| 2010's | 30 (55.56) | 24.3611 |
| 2020's | 19 (35.19) | 2.80 |
| Authors | Studies |
|---|---|
| Mulrenin, IR | 1 |
| Garcia, JE | 1 |
| Fashe, MM | 1 |
| Loop, MS | 1 |
| Daubert, MA | 1 |
| Urrutia, RP | 1 |
| Lee, CR | 1 |
| Ashworth, D | 1 |
| Battersby, C | 1 |
| Green, M | 1 |
| Hardy, P | 1 |
| McManus, RJ | 1 |
| Cluver, C | 1 |
| Chappell, LC | 1 |
| Wu, HZ | 1 |
| Cheng, Y | 1 |
| Yu, D | 1 |
| Li, JB | 1 |
| Jiang, YF | 1 |
| Zhu, ZN | 1 |
| Dublin, S | 1 |
| Idu, A | 1 |
| Avalos, LA | 1 |
| Cheetham, TC | 1 |
| Easterling, TR | 1 |
| Chen, L | 2 |
| Holt, VL | 1 |
| Nance, N | 1 |
| Bider-Canfield, Z | 1 |
| Neugebauer, RS | 1 |
| Reynolds, K | 1 |
| Badon, SE | 1 |
| Shortreed, SM | 1 |
| George, R | 1 |
| Thomas, C | 1 |
| Joy, CA | 1 |
| Varghese, B | 1 |
| Undela, K | 1 |
| Adela, R | 1 |
| Do, SC | 1 |
| Leonard, SA | 1 |
| Kan, P | 1 |
| Panelli, DM | 1 |
| Girsen, AI | 1 |
| Lyell, DJ | 1 |
| El-Sayed, YY | 1 |
| Druzin, ML | 1 |
| Herrero, T | 1 |
| van de Vusse, D | 1 |
| Mian, P | 1 |
| Schoenmakers, S | 1 |
| Flint, RB | 1 |
| Visser, W | 1 |
| Allegaert, K | 1 |
| Versmissen, J | 1 |
| Shao, Y | 1 |
| Gu, S | 1 |
| Zhang, X | 1 |
| Kipnis, CM | 1 |
| Daly, PL | 1 |
| Goodwin, ET | 1 |
| Smith, DK | 1 |
| Fishel Bartal, M | 1 |
| Blackwell, SC | 1 |
| Pedroza, C | 1 |
| Lawal, D | 1 |
| Amro, F | 1 |
| Samuel, J | 1 |
| Chauhan, SP | 1 |
| Sibai, BM | 1 |
| Wasif, U | 1 |
| Al-Shehab, U | 1 |
| Lo, DF | 1 |
| Ou, M | 1 |
| Zhang, F | 1 |
| Cui, S | 1 |
| Zhao, S | 1 |
| Yu, Y | 1 |
| Bajpai, D | 1 |
| Popa, C | 1 |
| Verma, P | 1 |
| Dumanski, S | 1 |
| Shah, S | 1 |
| Salama, M | 1 |
| Rezk, M | 1 |
| Gaber, W | 1 |
| Hamza, H | 1 |
| Marawan, H | 1 |
| Gamal, A | 1 |
| Abdallah, S | 1 |
| Alavifard, S | 1 |
| Chase, R | 1 |
| Janoudi, G | 1 |
| Chaumont, A | 1 |
| Lanes, A | 1 |
| Walker, M | 1 |
| Gaudet, L | 1 |
| Kantorowska, A | 1 |
| Heiselman, CJ | 1 |
| Halpern, TA | 1 |
| Akerman, MB | 1 |
| Elsayad, A | 1 |
| Muscat, JC | 1 |
| Sicuranza, GB | 1 |
| Vintzileos, AM | 1 |
| Heo, HJ | 1 |
| Ekawati, FM | 1 |
| Lau, P | 1 |
| Tolcher, MC | 1 |
| Fox, KA | 1 |
| Sangi-Haghpeykar, H | 1 |
| Clark, SL | 1 |
| Belfort, MA | 1 |
| Thakur, M | 1 |
| Gainder, S | 1 |
| Saha, SC | 1 |
| Prakash, M | 1 |
| Martin, C | 1 |
| Pappas, J | 1 |
| Johns, K | 1 |
| Figueroa, H | 1 |
| Balli, K | 1 |
| Yao, R | 1 |
| Mary, S | 1 |
| Small, HY | 1 |
| Siwy, J | 1 |
| Mullen, W | 1 |
| Giri, A | 1 |
| Delles, C | 1 |
| Sharma, KJ | 1 |
| Kilpatrick, SJ | 2 |
| Sharma, C | 2 |
| Soni, A | 1 |
| Gupta, A | 1 |
| Verma, A | 1 |
| Verma, S | 2 |
| Wang, Y | 1 |
| Shi, D | 1 |
| Shawkat, E | 1 |
| Mistry, H | 1 |
| Chmiel, C | 1 |
| Webster, L | 1 |
| Chappell, L | 1 |
| Johnstone, ED | 1 |
| Myers, JE | 1 |
| Chen, H | 1 |
| Li, X | 1 |
| Wu, Y | 1 |
| Fan, L | 1 |
| Tian, G | 1 |
| Miller, MJ | 1 |
| Butler, P | 1 |
| Gilchriest, J | 1 |
| Taylor, A | 1 |
| Lutgendorf, MA | 1 |
| Zulfeen, M | 1 |
| Tatapudi, R | 1 |
| Sowjanya, R | 1 |
| Reddy, S | 1 |
| Jim, B | 1 |
| Zhang, Z | 1 |
| Lu, J | 1 |
| Qin, X | 1 |
| Easterling, T | 1 |
| Mundle, S | 1 |
| Bracken, H | 1 |
| Parvekar, S | 1 |
| Mool, S | 1 |
| Magee, LA | 4 |
| von Dadelszen, P | 3 |
| Shochet, T | 1 |
| Winikoff, B | 1 |
| Arulkumaran, N | 1 |
| Lightstone, L | 1 |
| Wang, L | 1 |
| Liu, ZQ | 1 |
| Huo, YQ | 1 |
| Yao, LJ | 1 |
| Wei, XG | 1 |
| Wang, YF | 1 |
| Shekhar, S | 2 |
| Thakur, S | 1 |
| Gizzo, S | 1 |
| Noventa, M | 1 |
| Saccardi, C | 1 |
| Paccagnella, G | 1 |
| Patrelli, TS | 1 |
| Cosmi, E | 1 |
| D'Antona, D | 1 |
| Firoz, T | 1 |
| MacDonell, K | 1 |
| Payne, BA | 1 |
| Gordon, R | 1 |
| Vidler, M | 1 |
| Vadhera, RB | 1 |
| Simon, M | 1 |
| Gupta, N | 2 |
| Kirubakaran, R | 1 |
| Pareek, P | 1 |
| Clark, SM | 1 |
| Dunn, HE | 1 |
| Hankins, GD | 1 |
| Olson-Chen, C | 1 |
| Seligman, NS | 1 |
| Abreo, A | 1 |
| Greene, N | 1 |
| Melsop, K | 1 |
| Peterson, N | 1 |
| Shields, LE | 1 |
| Main, EK | 1 |
| Liu, Z | 1 |
| Wang, XY | 1 |
| Yan, NN | 1 |
| Ozsvár, Z | 1 |
| Solymossi, Z | 1 |
| Monostory, K | 1 |
| Folic, MM | 1 |
| Jankovic, SM | 1 |
| Varjacic, MR | 1 |
| Folic, MD | 1 |
| Yee, LM | 1 |
| Wu, D | 1 |
| Raheem, IA | 1 |
| Saaid, R | 1 |
| Omar, SZ | 1 |
| Tan, PC | 1 |
| Vasapollo, B | 1 |
| Novelli, GP | 1 |
| Gagliardi, G | 1 |
| Tiralongo, GM | 1 |
| Pisani, I | 1 |
| Manfellotto, D | 1 |
| Giannini, L | 1 |
| Valensise, H | 1 |
| Giannubilo, SR | 1 |
| Bezzeccheri, V | 1 |
| Cecchi, S | 1 |
| Landi, B | 1 |
| Battistoni, GI | 1 |
| Vitali, P | 1 |
| Cecchi, L | 1 |
| Tranquilli, AL | 1 |
| Verhagen, EA | 1 |
| Kooi, EM | 1 |
| van den Berg, PP | 1 |
| Bos, AF | 1 |
| Côté, AM | 1 |
| Heazell, AE | 1 |
| Mahomoud, S | 1 |
| Pirie, AM | 1 |
| Herrera, JA | 1 |
| Arévalo-Herrera, M | 1 |
| Shahabuddin, AK | 1 |
| Ersheng, G | 1 |
| Herrera, S | 1 |
| Garcia, RG | 1 |
| López-Jaramillo, P | 1 |
| Dalmia, S | 1 |
| Deka, D | 1 |
| Mittal, S | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Oral Antihypertensive Regimens for Management of Hypertension in Pregnancy[NCT01912677] | Phase 4 | 894 participants (Actual) | Interventional | 2015-04-30 | Completed | ||
| Use of Sildenafil Citrate in Management of Mild Pre-eclampsia: A Randomized Controlled Trial[NCT03262961] | Phase 2/Phase 3 | 80 participants (Anticipated) | Interventional | 2016-09-15 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
16 reviews available for nifedipine and Hypertension, Pregnancy-Induced
| Article | Year |
|---|---|
The Impact of Pregnancy on Antihypertensive Drug Metabolism and Pharmacokinetics: Current Status and Future Directions.
Topics: Antihypertensive Agents; Female; Humans; Hypertension, Pregnancy-Induced; Labetalol; Nifedipine; Pha | 2021 |
Different dosage regimens of nifedipine, labetalol, and hydralazine for the treatment of severe hypertension during pregnancy: a network meta-analysis of randomized controlled trials.
Topics: Antihypertensive Agents; Blood Pressure; Female; Humans; Hydralazine; Hypertension; Hypertension, Pr | 2022 |
Comparative efficacy and safety of oral nifedipine with other antihypertensive medications in the management of hypertensive disorders of pregnancy: a systematic review and meta-analysis of randomized controlled trials.
Topics: Antihypertensive Agents; Female; Humans; Hypertension, Pregnancy-Induced; Nifedipine; Pregnancy; Pre | 2022 |
Pharmacokinetics of the most commonly used antihypertensive drugs throughout pregnancy methyldopa, labetalol, and nifedipine: a systematic review.
Topics: Antihypertensive Agents; Female; Humans; Hypertension; Hypertension, Pregnancy-Induced; Labetalol; M | 2022 |
Oral nifedipine may be a preferential option for treating acute severe hypertension during pregnancy: a meta-analysis.
Topics: Blood Pressure; Female; Humans; Hypertension, Pregnancy-Induced; Labetalol; Nifedipine; Pregnancy | 2023 |
Evaluation and Management of Hypertensive Disorders of Pregnancy.
Topics: Antihypertensive Agents; Female; Humans; Hypertension, Pregnancy-Induced; Infant, Newborn; Labetalol | 2023 |
First-line antihypertensive treatment for severe hypertension in pregnancy: A systematic review and network meta-analysis.
Topics: Antihypertensive Agents; Female; Humans; Hypertension, Pregnancy-Induced; Nifedipine; Pregnancy; Pre | 2019 |
Postpartum Hypertension: Etiology, Diagnosis, and Management.
Topics: Antihypertensive Agents; Blood Pressure; Disease Management; Female; Humans; Hydralazine; Hypertensi | 2017 |
Hypertension and Pregnancy: Management and Future Risks.
Topics: Antihypertensive Agents; Aspirin; Cardiovascular Diseases; Chronic Disease; Diuretics; Female; Human | 2019 |
Severe pre-eclampsia and hypertensive crises.
Topics: Administration, Intravenous; Administration, Oral; Antihypertensive Agents; Critical Care; Early Dia | 2013 |
Twin pregnancy after kidney transplantation: what's on? A case report and review of literature.
Topics: Adult; Anemia; Female; Humans; Hypertension, Pregnancy-Induced; Iron; Kidney Transplantation; Methyl | 2014 |
Oral antihypertensive therapy for severe hypertension in pregnancy and postpartum: a systematic review.
Topics: Administration, Oral; Antihypertensive Agents; Female; Humans; Hydralazine; Hypertension, Pregnancy- | 2014 |
Hypertensive emergencies in pregnancy.
Topics: Antihypertensive Agents; Eclampsia; Emergencies; Female; Humans; Hydralazine; Hypertension; Hyperten | 2014 |
Oral nifedipine versus intravenous labetalol for severe hypertension during pregnancy: a systematic review and meta-analysis.
Topics: Administration, Intravenous; Administration, Oral; Adult; Antihypertensive Agents; Cost-Benefit Anal | 2016 |
A review of oral labetalol and nifedipine in mild to moderate hypertension in pregnancy.
Topics: Administration, Oral; Adult; Antihypertensive Agents; Blood Pressure; Female; Humans; Hypertension, | 2015 |
Hypertensive Emergencies in Pregnancy.
Topics: Antihypertensive Agents; Cesarean Section; Chronic Disease; Congenital Abnormalities; Emergencies; E | 2016 |
15 trials available for nifedipine and Hypertension, Pregnancy-Induced
| Article | Year |
|---|---|
Effects of Nifedipine and Labetalol Combined with Magnesium Sulfate on Blood Pressure Control, Blood Coagulation Function, and Maternal and Infant Outcome in Patients with Pregnancy-Induced Hypertension.
Topics: Antihypertensive Agents; Blood Coagulation; Blood Pressure; Female; Humans; Hypertension; Hypertensi | 2022 |
Oral combined hydrochlorothiazide and lisinopril vs nifedipine for postpartum hypertension: a comparative-effectiveness pilot randomized controlled trial.
Topics: Antihypertensive Agents; Bayes Theorem; Blood Pressure; Double-Blind Method; Female; Humans; Hydroch | 2023 |
Methyldopa versus nifedipine or no medication for treatment of chronic hypertension during pregnancy: A multicenter randomized clinical trial.
Topics: Administration, Oral; Adult; Antihypertensive Agents; Egypt; Female; Humans; Hypertension; Hypertens | 2019 |
Intravenous labetalol versus oral nifedipine for acute hypertension in pregnancy: effects on cerebral perfusion pressure.
Topics: Administration, Oral; Adult; Antihypertensive Agents; Cerebrovascular Circulation; Cohort Studies; F | 2020 |
To study the changes in maternal hemodynamics with intravenous labetalol or nifedipine in acute severe hypertension.
Topics: Administration, Intravenous; Administration, Oral; Adult; Antihypertensive Agents; Blood Pressure; F | 2020 |
Hydralazine vs nifedipine for acute hypertensive emergency in pregnancy: a randomized controlled trial.
Topics: Acute Disease; Adolescent; Adult; Apgar Score; Double-Blind Method; Emergencies; Female; Humans; Hyd | 2017 |
Lipid profile and cytokines in hypertension of pregnancy: A comparison of preeclampsia therapies.
Topics: Adult; Antihypertensive Agents; Blood Pressure; Cytokines; Double-Blind Method; Drug Administration | 2018 |
Implementation of a standardized nurse initiated protocol to manage severe hypertension in pregnancy.
Topics: Administration, Oral; Antihypertensive Agents; Blood Pressure Determination; Clinical Protocols; Dru | 2020 |
IV labetalol and oral nifedipine in acute control of severe hypertension in pregnancy-A randomized controlled trial.
Topics: Administration, Intravenous; Administration, Oral; Antihypertensive Agents; Double-Blind Method; Fem | 2019 |
Oral antihypertensive regimens (nifedipine retard, labetalol, and methyldopa) for management of severe hypertension in pregnancy: an open-label, randomised controlled trial.
Topics: Administration, Oral; Adult; Antihypertensive Agents; Blood Pressure; Female; Humans; Hypertension, | 2019 |
Oral nifedipine or intravenous labetalol for hypertensive emergency in pregnancy: a randomized controlled trial.
Topics: Administration, Intravenous; Administration, Oral; Adult; Antihypertensive Agents; Blood Pressure; D | 2013 |
[Treatment of albuminuria in gestational hypertension puerpera in the severe preeclampeia stage by TCM therapy for stasis-removing and diuresis].
Topics: Adult; Albuminuria; Diagnosis, Differential; Drug Therapy, Combination; Drugs, Chinese Herbal; Femal | 2009 |
Oral nifedipine versus intravenous labetalol for acute blood pressure control in hypertensive emergencies of pregnancy: a randomised trial.
Topics: Administration, Oral; Adult; Antihypertensive Agents; Blood Pressure; Double-Blind Method; Emergenci | 2012 |
Medical treatment of early-onset mild gestational hypertension reduces total peripheral vascular resistance and influences maternal and fetal complications.
Topics: Adult; Antihypertensive Agents; Blood Pressure; Echocardiography; Female; Humans; Hypertension, Preg | 2012 |
Calcium and conjugated linoleic acid reduces pregnancy-induced hypertension and decreases intracellular calcium in lymphocytes.
Topics: Administration, Oral; Adolescent; Adult; Angiotensin II; Blood Pressure; Calcium; Calcium Channel Bl | 2006 |
23 other studies available for nifedipine and Hypertension, Pregnancy-Induced
| Article | Year |
|---|---|
Which antihypertensive treatment is better for mild to moderate hypertension in pregnancy?
Topics: Antihypertensive Agents; Female; Humans; Hypertension, Pregnancy-Induced; Labetalol; Methyldopa; Nif | 2022 |
Maternal and neonatal outcomes of antihypertensive treatment in pregnancy: A retrospective cohort study.
Topics: Antihypertensive Agents; Birth Weight; Female; Humans; Hypertension, Pregnancy-Induced; Infant; Infa | 2022 |
Postpartum Readmission for Hypertension After Discharge on Labetalol or Nifedipine.
Topics: Antihypertensive Agents; Cohort Studies; Female; Humans; Hypertension; Hypertension, Pregnancy-Induc | 2022 |
Hypertensive Conditions: Hypertensive Disorders in Pregnancy.
Topics: Antihypertensive Agents; Female; Humans; Hypertension, Pregnancy-Induced; Labetalol; Nifedipine; Pre | 2022 |
Critical commentary on labetalol and nifedipine use in postpartum hypertension management.
Topics: Antihypertensive Agents; Blood Pressure; Female; Humans; Hypertension; Hypertension, Pregnancy-Induc | 2023 |
Identification of factors associated with delayed treatment of obstetric hypertensive emergencies.
Topics: Administration, Intravenous; Administration, Oral; Adult; After-Hours Care; Antihypertensive Agents; | 2020 |
What if there is no reliable and appropriate medication for pregnancy hypertension available in Indonesian primary care?
Topics: Antihypertensive Agents; Female; Humans; Hypertension, Pregnancy-Induced; Indonesia; Maternal Health | 2020 |
Semiautonomous Treatment Algorithm for the Management of Severe Hypertension in Pregnancy.
Topics: Adult; Algorithms; Antihypertensive Agents; Female; Humans; Hypertension, Pregnancy-Induced; Labetal | 2021 |
Polymerization-Incompetent Uromodulin in the Pregnant Stroke-Prone Spontaneously Hypertensive Rat.
Topics: Animals; Antihypertensive Agents; Female; Hypertension, Pregnancy-Induced; Kidney; Nifedipine; Polym | 2017 |
The effect of labetalol and nifedipine MR on blood pressure in women with chronic hypertension in pregnancy.
Topics: Adrenergic Antagonists; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Chronic D | 2018 |
Pregnancy-induced complications in IgA nephropathy: A case report.
Topics: Adult; Antihypertensive Agents; Benzimidazoles; Benzoates; Biopsy; Blood Pressure; Cyclophosphamide; | 2018 |
Case Report: Optical Coherence Tomography Can Find Typical Features in Pregnancy-induced Hypertension with Retinopathy.
Topics: Adult; Blood Pressure; Drug Therapy, Combination; Female; Fluorescein Angiography; Humans; Hypertens | 2019 |
Change of hs-CRP, sVCAM-1, NT-proBNP levels in patients with pregnancy-induced hypertension after therapy with magnesium sulfate and nifedipine.
Topics: Adult; Antihypertensive Agents; Biomarkers; C-Reactive Protein; Calcium Channel Blockers; Endotheliu | 2013 |
Oral nifedipine or intravenous labetalol for severe hypertension?
Topics: Antihypertensive Agents; Female; Humans; Hypertension, Pregnancy-Induced; Labetalol; Nifedipine; Pra | 2016 |
Severe maternal morbidity in a large cohort of women with acute severe intrapartum hypertension.
Topics: Adult; Antihypertensive Agents; California; Female; Humans; Hydralazine; Hypertension, Pregnancy-Ind | 2016 |
[Methyldopa-induced acute reactive hepatitis in pregnancy, drug-metabolizing capacity of the liver].
Topics: Adrenergic alpha-Agonists; Adult; Antihypertensive Agents; Aryl Hydrocarbon Hydroxylases; Blood Pres | 2010 |
Effects of methyldopa and nifedipine on uteroplacental and fetal hemodynamics in gestational hypertension.
Topics: Adult; Antihypertensive Agents; Female; Hemodynamics; Humans; Hypertension, Pregnancy-Induced; Methy | 2012 |
False-positive amphetamine toxicology screen results in three pregnant women using labetalol.
Topics: Adult; Amphetamine; Antihypertensive Agents; Cesarean Section; Chronic Disease; Cocaine; Cross React | 2011 |
Nifedipine versus labetalol in the treatment of hypertensive disorders of pregnancy.
Topics: Adrenergic beta-Antagonists; Calcium Channel Blockers; Female; Humans; Hypertension, Pregnancy-Induc | 2012 |
Maternal antihypertensive drugs may influence cerebral oxygen extraction in preterm infants during the first days after birth.
Topics: Antihypertensive Agents; Case-Control Studies; Cerebral Cortex; Cerebrovascular Circulation; Female; | 2013 |
Nifedipine for severe hypertension in pregnancy: emotion or evidence?
Topics: Acute Disease; Canada; Capsules; Female; Humans; Hypertension, Pregnancy-Induced; Nifedipine; Pregna | 2005 |
The treatment of severe hypertension in pregnancy: a review of current practice and knowledge in West-Midlands maternity units.
Topics: Antihypertensive Agents; Female; Hospital Units; Humans; Hydralazine; Hypertension, Pregnancy-Induce | 2004 |
Successful maternal and fetal outcome in a pregnancy with type V Takayasu's aortoarteritis.
Topics: Adult; Antihypertensive Agents; Arterial Occlusive Diseases; Calcium Channel Blockers; Diuretics; Fe | 2008 |